UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (362) 362
life sciences & biomedicine (360) 360
platinum-based chemotherapy (299) 299
humans (282) 282
oncology (256) 256
female (214) 214
chemotherapy (213) 213
middle aged (181) 181
cancer (164) 164
aged (150) 150
adult (136) 136
antineoplastic combined chemotherapy protocols - therapeutic use (130) 130
male (130) 130
lung neoplasms - drug therapy (118) 118
carcinoma, non-small-cell lung - drug therapy (100) 100
prognosis (88) 88
lung cancer (87) 87
treatment outcome (85) 85
neoplasm staging (75) 75
care and treatment (67) 67
ovarian cancer (67) 67
aged, 80 and over (65) 65
antineoplastic agents - therapeutic use (65) 65
cisplatin - administration & dosage (63) 63
retrospective studies (62) 62
lung neoplasms - pathology (58) 58
analysis (56) 56
lung cancer, non-small cell (55) 55
platinum (55) 55
non-small cell lung cancer (54) 54
lung neoplasms - genetics (53) 53
disease-free survival (50) 50
carcinoma, non-small-cell lung - genetics (47) 47
carcinoma, non-small-cell lung - pathology (47) 47
ovarian neoplasms - drug therapy (47) 47
survival rate (46) 46
lung neoplasms - mortality (45) 45
obstetrics & gynecology (44) 44
antineoplastic combined chemotherapy protocols - adverse effects (43) 43
pharmacology & pharmacy (41) 41
research (41) 41
cancer therapies (40) 40
hematology, oncology and palliative medicine (40) 40
carcinoma, non-small-cell lung - mortality (38) 38
cisplatin (38) 38
carboplatin - administration & dosage (37) 37
genetic aspects (35) 35
platinum‐based chemotherapy (35) 35
cisplatin - therapeutic use (34) 34
patients (33) 33
patient outcomes (32) 32
medical prognosis (31) 31
meta-analysis (31) 31
ovarian neoplasms - pathology (31) 31
respiratory system (31) 31
survival analysis (31) 31
tumors (31) 31
polymorphism (30) 30
ercc1 (29) 29
toxicity (29) 29
platinum - therapeutic use (28) 28
medicine & public health (27) 27
surgery (27) 27
cancer research (26) 26
chemotherapy, adjuvant (26) 26
combined modality therapy (26) 26
lung cancer, small cell (26) 26
health aspects (25) 25
nsclc (25) 25
paclitaxel - administration & dosage (25) 25
quality of life (25) 25
deoxyribonucleic acid--dna (24) 24
follow-up studies (24) 24
metastasis (24) 24
non-small-cell lung cancer (24) 24
survival (24) 24
adenocarcinoma - drug therapy (23) 23
dna-binding proteins - genetics (23) 23
immunohistochemistry (23) 23
oncology, experimental (23) 23
carboplatin - therapeutic use (22) 22
deoxycytidine - analogs & derivatives (22) 22
development and progression (22) 22
dna repair (22) 22
genotype (22) 22
polymorphism, single nucleotide (22) 22
pulmonary/respiratory (22) 22
antineoplastic agents - adverse effects (21) 21
biomarkers (21) 21
carboplatin (21) 21
carcinoma, squamous cell - drug therapy (21) 21
deoxycytidine - administration & dosage (21) 21
original (21) 21
young adult (21) 21
cisplatin - adverse effects (20) 20
drug resistance, neoplasm (20) 20
mutation (20) 20
antineoplastic agents (19) 19
apoptosis (19) 19
drug resistance (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (470) 470
Japanese (3) 3
Russian (3) 3
French (2) 2
German (2) 2
Korean (2) 2
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of cancer (1990), ISSN 0959-8049, 07/2014, Volume 50, Issue 10, pp. 1819 - 1828
Abstract Background Platinum-based chemotherapy is the most common treatment in advanced-stage lung adenocarcinoma... 
Hematology, Oncology and Palliative Medicine | KRAS mutation | Advanced-stage lung adenocarcinoma | Platinum-based chemotherapy | Non-small cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Smoking - adverse effects | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Multivariate Analysis | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Patient Selection | Time Factors | DNA Mutational Analysis | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Adenocarcinoma - ethnology | Lung Neoplasms - genetics | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Risk Factors | Hungary - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Proto-Oncogene Proteins - genetics | Treatment Outcome | Chi-Square Distribution | Adenocarcinoma - drug therapy | Smoking - ethnology | Disease-Free Survival | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma | Medical research | Care and treatment | Chemotherapy | Analysis | Medicine, Experimental | Genetic aspects | Cancer | Index Medicus
Journal Article
The oncologist (Dayton, Ohio), ISSN 1549-490X, 07/2019, Volume 24, Issue 12, pp. e1471 - e1475
.... Our objective was to assess chemotherapy‐associated toxicities in patients with epithelial ovarian cancer with and without a germline BRCA mutation... 
Chemotherapy toxicity | Epithelial ovarian cancer | BRCA mutations | Platinum‐based chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus | Gynecologic Oncology
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 05/2017, Volume 8, Issue 43, pp. 75617 - 75626
Background: Anthracycline-and taxane-based adjuvant chemotherapies are the most frequently used systemic treatments for women with triple negative breast cancer (TNBC... 
Carboplatin | Chemotherapy | Early breast cancer | Platinum-based chemotherapy | Triple negative breast cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology
Journal Article
Oncotarget, ISSN 1949-2553, 12/2016, Volume 8, Issue 9, pp. 16036 - 16051
...), progression-free survival (PFS), disease-free survival (DFS) and treatment response (TR) of cancer patients who received chemotherapy based on published literatures, the Gene Expression Omnibus (GEO... 
Lung cancer | Platinum-based chemotherapy | CTR1 | Meta-analysis | Ovarian cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Prognosis | Cation Transport Proteins - metabolism | Humans | Copper - metabolism | Survival Analysis | Neoplasms - mortality | Neoplasms - drug therapy | Index Medicus
Journal Article
International journal of environmental research and public health, ISSN 1661-7827, 06/2016, Volume 13, Issue 6, p. 545
Journal Article
Journal Article